Consequences of diethylstilbestrol during pregnancy: Still an important subject after fifty years;Gevolgen van diëthylstilbestrol in de zwangerschap: Na 50 jaar nog steeds een actueel probleem

Nederlands Tijdschrift voor Geneeskunde

Volumn 145, Issue 14, 2001, Pages 675-680

  Treffers, P E ^a   Hanselaar, A G J M ^a   Helmerhorst, Th J M ^a   Koster, M E T A ^a   Van Leeuwen, F E ^a  

^a Emeritus Hoogler Verlosk Gynaecol   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DIETHYLSTILBESTROL;

ABORTION; AGE; BREAST CARCINOMA; CANCER INCIDENCE; CANCER RISK; CLEAR CELL CARCINOMA; DEVELOPMENTAL DISORDER; ECTOPIC PREGNANCY; FEMALE FERTILITY; GYNECOLOGIC CANCER; GYNECOLOGIC DISEASE; HUMAN; NONHUMAN; PREMATURITY; REVIEW; RISK ASSESSMENT; TESTIS CARCINOMA;

ADENOCARCINOMA, CLEAR CELL; ADULT; ANIMALS; BREAST NEOPLASMS; CARCINOGENS; DIETHYLSTILBESTROL; FEMALE; GENITAL DISEASES, FEMALE; GENITAL NEOPLASMS, FEMALE; GENITALIA; HUMANS; INCIDENCE; MALE; MEDICAL RECORDS; MICE; MIDDLE AGED; NETHERLANDS; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL EXPOSURE DELAYED EFFECTS;

EID: 0035820355     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (60)

1. Oestrogenic activity of certain synthetic compounds
2. Diethylstilbestrol in the prevention and treatment of complications of pregnancy
3. The influence of diethylstilbestrol on the progress and outcome of pregnancy as based on a comparison of treated with untreated primigravidas
4. Does administration of diethylstilbestrol during pregnancy have therapeutic value?
5. Diethylstilbestrol in pregnancy. Frequency of exposure and usage patterns
6. DES European Study
7. Habituele abortus
8. Diaethylstilboestrol in de zwangerschap
9. Toediening van hormoonpreparaten bij dreigende miskraam
10. Adenocarcinoma of the vagina in adolescence. A report of 7 cases including 6 clear-cell carcinomas (so-called mesonephromas)
11. Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women
12. Diethylstilbestrol revisited: A review of the long-term health effects
13. Design and preliminary observations of the National Cooperative Diethylstilbestrol Adenosis (DESAD) project
14. Breast cancer in mothers given diethylstilbestrol in pregnancy
15. Clear cell adenocarcinoma of the vagina and cervix secondary to intrauterine exposure to diethylstilbestrol
16. A twenty-five-year follow-up study of women exposed to diethylstilbestrol during pregnancy
17. Breast cancer in mothers prescribed diethylstilbestrol in pregnancy
18. Diethylstilbestrol and risk of fatal breast cancer in a prospective cohort of US women
19. Rates and risks of diethylstilbestrol-related clear cell adenocarcinoma of the vagina and cervix. An update
20. Epidemiologic aspects and factors related to survival in 384 registry cases of clear cell adenocarcinoma of the vagina and cervix
21. Increased incidence of cervical and vaginal dysplasia in 3980 diethylstilbestrol-exposed young women. Experience of the National Collaborative Diethylstilbestrol Adenosis Project
22. Topographic relation of cervical ectropion and vaginal adenosis to clear cell adenocarcinoma
23. Upper genital tract changes and pregnancy outcome in offspring exposed in utero to diethylstilbestrol
24. Upper genital tract changes and infertility in diethylstilbestrol-exposed women
25. Follow-up study of male and female offspring of DES-exposed mothers
26. Infertility among daughters either exposed or not exposed to stilbestrol
27. Fertility and outcome of pregnancy in women exposed in utero to diethylstilbestrol
28. Infertility among women exposed prenatally to diethylstilbestrol
29. Pregnancy outcome in DES daughters
30. Association of diethylstilbestrol exposure in utero with cryptorchism, testicular hypoplasia and semen abnormalities
31. Fertility in men exposed prenatally to diethylstilbestrol
32. Vaginacarcinoom bij een jonge vrouw
33. Vaginacarcinoom na diëthylstilbestrolmedicatie bij een 17-jarig meisje
34. Diëthylstilbestrol, zwangerschap en carcinogenese
35. Het teratogene effect van diëthylstilbestrol in de zwangerschap; de omvang van het DES-probleem in Nederland
36. Colposcopic findings and intraepithelial neoplasia in diethylstilbestrol-exposed offspring. The Dutch experience
37. Nieuwe richtlijnen voor gynaecologisch onderzoek bij DES-dochters
38. Clear cell adenocarcinoma of the vagina and cervix. An update of the central Netherlands registry showing twin age incidence peaks
39. 'Clear cell'-adenocarcinoom van vagina en cervix niet alleen door blootstelling aan diëthylstilbestrol
40. Cytologic examination to detect clear cell adenocarcinoma of the vagina or cervix
41. DES, meer dan een oncologisch probleem
42. Vruchtbaarheid en zwangerschap na intra-uteriene blootstelling aan diethylstilbestrol (DES)
43. Gynaecologische en obstetrische consequenties van blootstelling aan diëthylstilbestrol (DES) in utero herbelicht
44. Gynaecologische en obstetrische consequenties van blootstelling aan diëthylstilbestrol (DES) in utero herbelicht
45. Gynaecologische en obstetrische consequenties van blootstelling aan diëthylstilbestrol (DES) in utero herbelicht
46. Gynaecologische en obstetrische consequenties van blootstelling aan diëthylstilbestrol (DES) in utero herbelicht
47. Bijdrage van DES aan het totale aantal vroeggeboorten in Nederland
48. Chromosoomtranslocatie bij een DES-dochter: Een toevallige bevinding?
49. Breast cancer and hormone replacement therapy: Collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancer
50. Cancer risk in women exposed to diethylstilbestrol in utero
51. Prevalence of gynecologic cancer in women exposed to diethylstilbestrol in utero
52. Hirsutism and menstrual patterns in women exposed to diethylstilbestrol in utero
53. Hyperprolactinaemia in diethylstilbestrol-exposed women
54. Diethylstilbestrol (DES)-related endocrine disturbances in women
55. Effects on the menstrual cycle of in utero exposure to diethylstilbestrol
56. Alterations in immune responsiveness in women exposed to diethylstilbestrol in utero
57. Increased occurrence of autoimmune disease among women exposed in utero to diethylstilbestrol
58. Increased tumors but uncompromised fertility in the female descendants of mice exposed developmentally to diethylstilbestrol
59. Proliferative lesions and reproductive tract tumors in male descendants of mice exposed developmentally to diethylstilbestrol